123 related articles for article (PubMed ID: 375178)
1. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications.
Rajani K; Goetzman BW; Wennberg RP; Turner E; Abildgaard C
Pediatrics; 1979 Apr; 63(4):552-6. PubMed ID: 375178
[TBL] [Abstract][Full Text] [Related]
2. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters.
Ankola PA; Atakent YS
Am J Perinatol; 1993 May; 10(3):229-32. PubMed ID: 8517902
[TBL] [Abstract][Full Text] [Related]
3. Prevention of umbilical artery catheter clots with heparinized infusates.
David RJ; Merten DF; Anderson JC; Gross S
Dev Pharmacol Ther; 1981; 2(2):117-26. PubMed ID: 7472106
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of risks associated with an umbilical artery catheter system for continuous monitoring of arterial oxygen tension.
Cohen RS; Ramachandran P; Kim EH; Glasscock GF
J Perinatol; 1995; 15(3):195-8. PubMed ID: 7666267
[TBL] [Abstract][Full Text] [Related]
5. Continuous blood gas monitoring using an in-dwelling optode method: clinical evaluation of the Neotrend sensor using a luer stub adaptor to access the umbilical artery catheter.
Rais-Bahrami K; Rivera O; Mikesell GT; Short BL
J Perinatol; 2002; 22(5):367-9. PubMed ID: 12082470
[TBL] [Abstract][Full Text] [Related]
6. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.
Kulkarni M; Elsner C; Ouellet D; Zeldin R
Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218
[TBL] [Abstract][Full Text] [Related]
7. Umbilical artery catheters in the newborn: effects of heparin.
Barrington KJ
Cochrane Database Syst Rev; 2000; 1999(2):CD000507. PubMed ID: 10796377
[TBL] [Abstract][Full Text] [Related]
8. Comparison of heparinized and nonheparinized solutions for maintaining patency of arterial and pulmonary artery catheters.
Zevola DR; Dioso J; Moggio R
Am J Crit Care; 1997 Jan; 6(1):52-5. PubMed ID: 9116787
[TBL] [Abstract][Full Text] [Related]
9. Nurses' guide to early detection of umbilical arterial catheter complications in infants.
Furdon SA; Horgan MJ; Bradshaw WT; Clark DA
Adv Neonatal Care; 2006 Oct; 6(5):242-56; quiz 257-60. PubMed ID: 17045945
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
de Neef M; Heijboer H; van Woensel JB; de Haan RJ
Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
[TBL] [Abstract][Full Text] [Related]
11. Obtaining blood samples for anti-factor Xa quantification through umbilical artery catheters.
Edstrom CS; McBride J; Theriaque D; Kao KJ; Christensen RD
J Perinatol; 2002 Sep; 22(6):475-7. PubMed ID: 12168126
[TBL] [Abstract][Full Text] [Related]
12. Umbilical arterial catheter use: report of an audit conducted by the Study Group for Complications of Perinatal Care.
Fletcher MA; Brown DR; Landers S; Seguin J
Am J Perinatol; 1994 Mar; 11(2):94-9. PubMed ID: 8198665
[TBL] [Abstract][Full Text] [Related]
13. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of a continuous intravascular neonatal blood gas sensor introduced through an umbilical artery catheter.
Meyers PA; Worwa C; Trusty R; Mammel MC
Respir Care; 2002 Jun; 47(6):682-7. PubMed ID: 12036438
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluids on life span of peripheral arterial lines.
Rais-Bahrami K; Karna P; Dolanski EA
Am J Perinatol; 1990 Apr; 7(2):122-4. PubMed ID: 2184811
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
[TBL] [Abstract][Full Text] [Related]
17. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
[TBL] [Abstract][Full Text] [Related]
18. Umbilical artery catheter position and intraventricular hemorrhage.
Schick JB; Beck AL; DeSilva HN
J Perinatol; 1989 Dec; 9(4):382-5. PubMed ID: 2593010
[TBL] [Abstract][Full Text] [Related]
19. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.
Clifton GD; Branson P; Kelly HJ; Dotson LR; Record KE; Phillips BA; Thompson JR
Heart Lung; 1991 Mar; 20(2):115-8. PubMed ID: 2004920
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma tissue factor levels in neonates with umbilical arterial catheter-associated thrombosis.
Tay SP; Cheong SK; Boo NY
Malays J Pathol; 2006 Jun; 28(1):41-8. PubMed ID: 17694958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
